Evidence map›Paper›PMID 20579973›Full record

ArticleBiological psychiatry2010

Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatients.

Udi E Ghitza, Kenzie L Preston, David H Epstein, Hiroto Kuwabara, Christopher J Endres, Badreddine Bencherif, Susan J Boyd, Marc L Copersino, J James Frost, David A Gorelick

Abstract read
In one paragraph

Article in Biological psychiatry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 65 citations in OpenAlex.

  1. Trial
  2. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2015
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Article
  9. The role of the opioid system in decision making and cognitive control: A review.Cognitive, affective & behavioral neuroscience · 2019
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Opioid Modulation of Value-Based Decision-Making in Healthy Humans.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Article
  16. Article
  17. Article
  18. Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological Gamblers.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Udi E GhitzaIntramural Research Program, Clinical Pharmacology and Therapeutics Research Branch, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland, USA. ghitzau@nida.nih.gov
Kenzie L Preston
David H Epstein
Hiroto Kuwabara
Christopher J Endres
Badreddine Bencherif
Susan J Boyd
Marc L Copersino
J James Frost
David A Gorelick
National Institute on Drug Abuse · USJohns Hopkins University · USJohns Hopkins Medicine · US

Funding

Prevention of Relapse in AddictionZIADA000536 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI PRESTON, KENZIE · 2009 to 2018
$9.5M
Evaluation Of Treatments Of Opioid And Cocaine DependenceZIADA000175 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI PRESTON, KENZIE · 2009 to 2016
$7.4M
Development Of New Pharmacologic And Biologic Treatments For Drug DependenceZIADA000240 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI HUESTIS, MARILYN A · 2009 to 2013
$894k
Identification Of Factors Associated With Response To Drugs And TreatmentZIADA000241 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI GORELICK, DAVID ALAN · 2009 to 2010
$515k
IMAGING OPIOID RECEPTORS IN COCAINE ADDICTION TREATMENTR01DA012274 · NIDA · JOHNS HOPKINS UNIVERSITY · PI FROST, J JAMES · 1998 to 2000
$407k
PET IMAGING OF OPIATE RECEPTORS IN COCAINE ABUSER01DA009479 · NIDA · JOHNS HOPKINS UNIVERSITY · PI FROST, J JAMES · 1994 to 1996
–
Intramural NIH HHS ZIA DA000240NIDA NIH HHS L30 DA021933NIDA NIH HHS R01 DA012274NIDA NIH HHS R01 DA-09479
6 · The paper itself

Abstract

backgroundCocaine users not seeking treatment have increased regional brain mu-opioid receptor (mOR) binding that correlates with cocaine craving and tendency to relapse. In cocaine-abusing outpatients in treatment, the relationship of mOR binding and treatment outcome is unknown.

methodsWe determined whether regional brain mOR binding before treatment correlates with outcome and compared it with standard clinical predictors of outcome. Twenty-five individuals seeking outpatient treatment for cocaine abuse or dependence (DSM-IV) received up to 12 weeks of cognitive-behavioral therapy and cocaine abstinence reinforcement, whereby each cocaine-free urine was reinforced with vouchers redeemable for goods. Regional brain mOR binding was measured before treatment using positron emission tomography with [¹¹C]]-carfentanil (a selective mOR agonist). Main outcome measures were: 1) overall percentage of urines positive for cocaine during first month of treatment; and 2) longest duration (weeks) of abstinence from cocaine during treatment, all verified by urine toxicology.

resultsElevated mOR binding in the medial frontal and middle frontal gyri before treatment correlated with greater cocaine use during treatment. Elevated mOR binding in the anterior cingulate, medial frontal, middle frontal, middle temporal, and sublobar insular gyri correlated with shorter duration of cocaine abstinence during treatment. Regional mOR binding contributed significant predictive power for treatment outcome beyond that of standard clinical variables such as baseline drug and alcohol use.

conclusionsElevated mOR binding in brain regions associated with reward sensitivity is a significant independent predictor of treatment outcome in cocaine-abusing outpatients, suggesting a key role for the brain endogenous opioid system in cocaine addiction.

Indexed as

AdultBrainCocaineCocaine-Related DisordersCognitive Behavioral TherapyFemaleFentanylHumansMagnetic Resonance ImagingMalePositron-Emission TomographyPredictive Value of TestsRadioligand AssayReceptors, Opioid, muTreatment OutcomecarfentanilCocaineFentanylReceptors, Opioid, mu

Identifiers

PMID20579973
PMCPMC2949457
OpenAlexW1993637332

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.